South Korea Biobanking Market (2026-2032) Outlook | Industry, Revenue, Companies, Size, Forecast, Analysis, Trends, Growth, Share & Value

Market Forecast By Type (Equipment, Consumables, Services, Software), By Applications (Regenerative Medicine, Life Science Research, Clinical Research), By Sample Type (Blood Products, Human Tissues, Nucleic Acids, Cell Lines, Biological Fluids, Human Waste Products) And Competitive Landscape
Product Code: ETC070062 Publication Date: Jun 2021 Updated Date: Jun 2026 Product Type: Report
Publisher: 6Wresearch Author: Ravi Bhandari No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

South Korea Biobanking Market Size, Share & Growth Rate

The South Korea Biobanking Market was estimated at USD 277 Million in 2025 and is projected to reach USD 369 Million by 2032, growing at a CAGR of 4.2% from 2026 to 2032. This growth trajectory is fueled by a combination of increasing investments in research and development, heightened awareness surrounding personalized medicine, and a significant rise in the demand for high-quality biological samples across various research applications. As the country embraces advanced biobanking technologies, it solidifies its position as a leader in the biomedical research landscape.

South Korea Biobanking Market Growth Rate Analysis (2021-2032)

The South Korean biobanking market exhibits stable growth, with projected yearly increases of 4.9% in 2021, followed by a slight dip to 4.8% in both 2022 and 2023. However, a rebound is anticipated with a growth rate of 5.1% in 2024. Factors driving this uptick include rising investments in healthcare infrastructure and enhanced consumer demand for personalized medicine. As the industry adapts to advancements in technology and digitalization, it maintains a robust outlook, sustaining growth rates of around 5% through 2029. Despite some fluctuations, such as the expected 4.6% growth in 2031, the market remains buoyed by effective policy frameworks and ongoing innovation, particularly in genomics and biopharmaceuticals.

South Korea Biobanking Market Year-wise Growth Rate and Key Drivers

This graph highlights how the South Korea Biobanking Market has steadily grown over the past five years, supported by major growth factors.

South Korea Biobanking Market Year-wise Growth Rate and Key Drivers

The table below presents the year‑wise growth rates along with the key drivers influencing the market

YearGrowth RateMajor Drivers
20214.9%Expansion of manufacturing activities
20224.8%Growing urbanization and commercial development
20234.8%Expansion of transportation and logistics networks
20245.1%Expansion of manufacturing activities
20254.9%Increasing industrial infrastructure investments
20264.8%Increasing smart city development projects
20275.0%Growing urbanization and commercial development
20285.0%Increasing industrial infrastructure investments
20295.0%Expansion of transportation and logistics networks
20304.7%Expansion of commercial construction activities
20314.6%Rising electricity demand across industries
20325.2%Expansion of commercial construction activities

Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.

South Korea Biobanking Market Synopsis

In recent years, the South Korea biobanking market has experienced robust momentum, supported by government initiatives and public-private collaborations. However, as the market evolves, it is on the brink of a transformative phase driven by advancements in precision medicine and an expanding array of research applications. This evolution promises not only to enhance the quality of research but also to elevate the country’s standing in global healthcare innovation.

The push towards integrating diverse biological samples into biobanks is changing the game, allowing for more comprehensive research into critical areas such as oncology and infectious diseases. As awareness of the value of biobanking grows among research communities and the general public alike, the market is set to thrive in the coming years, underpinned by a strong foundation of academic and industrial collaboration.

South Korea Biobanking Market Key Takeaways

  • The market is transitioning towards a focus on precision medicine and personalized healthcare solutions.
  • Government policies are fostering innovation and establishing regulatory frameworks for ethical biobanking practices.
  • Technological advancements are paving the way for enhanced sample management and data security in biobanking operations.
  • Collaborations among biobanks, academia, and industry are increasing, facilitating rapid research advancements.
  • Investment opportunities are emerging in automated systems and integrated data-sharing technologies.

Evaluation of Restraints in South Korea Biobanking Market

Despite its potential, the South Korea biobanking market faces several restraints. Regulatory complexities regarding the collection, storage, and sharing of biological samples pose significant challenges for biobanks. Moreover, there is a pressing need for standardized procedures and robust data management practices to ensure reliability and integrity. The general public's limited understanding of biobanking's importance can also hamper donor participation, which is crucial for expanding sample collections. Addressing these challenges will be essential for unlocking the full potential of the market and facilitating ongoing advancements in healthcare and research.

South Korea Biobanking Market Trends

A number of current and emerging trends are shaping the South Korea biobanking market. The adoption of advanced technologies, including automated sample storage systems and AI-driven data analysis, is transforming the operational landscape. Furthermore, there is an increasing emphasis on broadening biobank collections to encompass diverse population groups, which enriches research capabilities. Enhanced focus on regulations and quality standards is also evident, ensuring the integrity of stored biological materials. Such trends highlight a future where biobanks are not merely storage facilities but pivotal players in health research and innovation.

South Korea Biobanking Market Opportunities

The South Korea biobanking market is ripe with opportunities for investment and growth. As demand for high-quality biological samples continues to rise, there is a growing need for state-of-the-art biobanking facilities equipped with advanced sample management systems and security protocols. Investors can also capitalize on the development of innovative technologies, such as blockchain for secure data sharing and machine learning for enhanced data processing. Collaborations with academic institutions and healthcare providers will further catalyze innovation and create pathways for novel therapeutic discoveries.

Government Initiatives in the South Korea Biobanking Market

The South Korean government is actively promoting the biobanking sector through robust policies and funding programs. The National Biobank of Korea Act plays a central role in governing the ethical collection, storage, and distribution of biological samples, ensuring compliance with safety and quality standards. Moreover, the Ministry of Food and Drug Safety is dedicated to maintaining stringent oversight of biobank practices, fostering a secure and ethical environment for research. This commitment to biobanking enhances the nation's infrastructure and encourages continued collaboration among various stakeholders.

Future Insights of the South Korea Biobanking Market

Looking ahead to 2026-2032, the South Korea biobanking market is expected to witness substantial growth driven by rising chronic disease prevalence and an aging population. The market's trajectory is bolstered by ongoing government initiatives aimed at promoting biobanking and precision medicine, alongside increasing healthcare investments. With advancements in medical research and technology, stakeholders can anticipate a thriving biobanking ecosystem, poised to make significant contributions to healthcare outcomes and innovative therapeutic solutions.

South Korea Biobanking Market Latest Developments (May 2025 - June 2026)

Recent developments in the South Korea biobanking market highlight an ongoing commitment to innovation and collaboration. Academic institutions are increasingly partnering with private sector entities to enhance research capabilities and expand biobank collections. Concurrently, there is a noticeable shift towards integrating advanced technologies in biobanking operations, aiming to streamline processes and improve data security. These evolving dynamics reflect a vibrant market actively seeking to leverage biobanking as a cornerstone of precision medicine and personalized healthcare.

South Korea Biobanking Market - Key Attractiveness of the Report

  • 10 Years of Market Numbers
  • Historical Data Starting from 2022 to 2025
  • Base Year: 2025
  • Forecast Data until 2032
  • Key Performance Indicators Impacting the Market
  • Major Upcoming Developments and Projects

Key Highlights of the Report:

  • South Korea Biobanking Market Outlook
  • Market Size of South Korea Biobanking Market, 2025
  • Forecast of South Korea Biobanking Market, 2032
  • Historical Data and Forecast of South Korea Biobanking Revenues & Volume for the Period 2022-2032F
  • South Korea Biobanking Market Trend Evolution
  • South Korea Biobanking Market Drivers and Challenges
  • South Korea Biobanking Price Trends
  • South Korea Biobanking Porter's Five Forces
  • South Korea Biobanking Industry Life Cycle
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Type for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Equipment for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Consumables for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Services for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Software for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Applications for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Regenerative Medicine for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Life Science Research for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Clinical Research for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Sample Type for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Blood Products for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Human Tissues for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Nucleic Acids for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Cell Lines for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Biological Fluids for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Biobanking Market Revenues & Volume By Human Waste Products for the Period 2022-2032F
  • South Korea Biobanking Import Export Trade Statistics
  • Market Opportunity Assessment By Type
  • Market Opportunity Assessment By Applications
  • Market Opportunity Assessment By Sample Type
  • South Korea Biobanking Top Companies Market Share
  • South Korea Biobanking Competitive Benchmarking By Technical and Operational Parameters
  • South Korea Biobanking Company Profiles
  • South Korea Biobanking Key Strategic Recommendations

South Korea Biobanking Market - Frequently Asked Questions

As of 2025, the South Korea biobanking market is estimated to be valued at USD 277 Million and is projected to reach USD 369 Million by 2032, growing at a CAGR of 4.2% from 2026 to 2032.
Government policies, such as the National Biobank of Korea Act, regulate the collection and distribution of biological samples, ensuring ethical practices and quality standards. These initiatives create a supportive environment for biobank development and innovation.
Key trends include the adoption of automated technologies, enhanced sample management systems, and a growing emphasis on diverse population samples for more comprehensive research outcomes.
Investors can explore opportunities in establishing advanced biobanks, investing in technologies for sample processing and data security, and forming collaborations with research institutions to accelerate innovation.
Biobanks are pivotal in advancing personalized medicine by providing high-quality biological samples that support research in genomics, cancer therapies, and other tailored healthcare solutions.
6Wresearch actively monitors the South Korea Biobanking Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the South Korea Biobanking Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 South Korea Biobanking Market Overview

3.1 South Korea Country Macro Economic Indicators

3.2 South Korea Biobanking Market Revenues & Volume, 2022 & 2032F

3.3 South Korea Biobanking Market - Industry Life Cycle

3.4 South Korea Biobanking Market - Porter's Five Forces

3.5 South Korea Biobanking Market Revenues & Volume Share, By Type, 2022 & 2032F

3.6 South Korea Biobanking Market Revenues & Volume Share, By Applications, 2022 & 2032F

3.7 South Korea Biobanking Market Revenues & Volume Share, By Sample Type, 2022 & 2032F

4 South Korea Biobanking Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for personalized medicine and genomic research

4.2.2 Government initiatives promoting biobanking and research activities

4.2.3 Growing prevalence of chronic diseases driving the need for large-scale sample storage and analysis

4.3 Market Restraints

4.3.1 Lack of awareness and understanding about the benefits of biobanking

4.3.2 Limited funding for biobanking infrastructure and research projects

4.3.3 Data privacy and ethical concerns related to the storage and use of biological samples

5 South Korea Biobanking Market Trends

6 South Korea Biobanking Market, By Types

6.1 South Korea Biobanking Market, By Type

6.1.1 Overview and Analysis

6.1.2 South Korea Biobanking Market Revenues & Volume, By Type, 2022-2032F

6.1.3 South Korea Biobanking Market Revenues & Volume, By Equipment, 2022-2032F

6.1.4 South Korea Biobanking Market Revenues & Volume, By Consumables, 2022-2032F

6.1.5 South Korea Biobanking Market Revenues & Volume, By Services, 2022-2032F

6.1.6 South Korea Biobanking Market Revenues & Volume, By Software, 2022-2032F

6.2 South Korea Biobanking Market, By Applications

6.2.1 Overview and Analysis

6.2.2 South Korea Biobanking Market Revenues & Volume, By Regenerative Medicine, 2022-2032F

6.2.3 South Korea Biobanking Market Revenues & Volume, By Life Science Research, 2022-2032F

6.2.4 South Korea Biobanking Market Revenues & Volume, By Clinical Research, 2022-2032F

6.3 South Korea Biobanking Market, By Sample Type

6.3.1 Overview and Analysis

6.3.2 South Korea Biobanking Market Revenues & Volume, By Blood Products, 2022-2032F

6.3.3 South Korea Biobanking Market Revenues & Volume, By Human Tissues, 2022-2032F

6.3.4 South Korea Biobanking Market Revenues & Volume, By Nucleic Acids, 2022-2032F

6.3.5 South Korea Biobanking Market Revenues & Volume, By Cell Lines, 2022-2032F

6.3.6 South Korea Biobanking Market Revenues & Volume, By Biological Fluids, 2022-2032F

6.3.7 South Korea Biobanking Market Revenues & Volume, By Human Waste Products, 2022-2032F

7 South Korea Biobanking Market Import-Export Trade Statistics

7.1 South Korea Biobanking Market Export to Major Countries

7.2 South Korea Biobanking Market Imports from Major Countries

8 South Korea Biobanking Market Key Performance Indicators

8.1 Number of collaborations between biobanks and research institutions

8.2 Growth in the number of samples stored in biobanks

8.3 Adoption rate of advanced technologies for sample processing and analysis

9 South Korea Biobanking Market - Opportunity Assessment

9.1 South Korea Biobanking Market Opportunity Assessment, By Type, 2022 & 2032F

9.2 South Korea Biobanking Market Opportunity Assessment, By Applications, 2022 & 2032F

9.3 South Korea Biobanking Market Opportunity Assessment, By Sample Type, 2022 & 2032F

10 South Korea Biobanking Market - Competitive Landscape

10.1 South Korea Biobanking Market Revenue Share, By Companies, 2025

10.2 South Korea Biobanking Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Leadership Perspectives from Industry Events

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Industry Events and Analyst Meet

Whitepaper

Read All